Cross Shawn 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Cross Shawn（CIK 1734779）在 1 家公司共报告 15 笔 SEC Form 4 内部人交易（最近一笔 2026-04-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-04-24 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 买入 | 12,941 | $212,879 |
| 2026-04-24 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 12,941 | $325,596 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 买入 | 7,714 | $126,895 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 7,714 | $193,930 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 买入 | 2,845 | $46,800 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 2,845 | $71,153 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 买入 | 1,500 | $24,675 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 1,500 | $37,515 |
| 2026-02-13 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 买入 | 49,091 | $0 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 买入 | 15,896 | $261,489 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 15,896 | $397,877 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 买入 | 9,104 | $149,761 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 9,104 | $228,875 |
| 2025-11-13 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 12,060 | $266,405 |
| 2025-11-03 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 卖出 | 6,690 | $143,032 |
来源：SEC Form 4 申报文件 · 截至 2026-04-24